Showing 6841-6850 of 8649 results for "".
- Gilead Inks Non-US Deals With Five Generic Drugmakers to Expand Supply of COVID-19 Drug Remdesivirhttps://modernod.com/news/gilead-inks-non-us-deals-with-five-generic-drugmakers-to-expand-supply-of-covid-19-drug-remdesivir/2477757/Gilead Sciences said it has signed non-exclusive voluntary licensing agreements with Cipla, Ferozsons Laboratories, Hetero Labs, Jubilant Lifesciences and Mylan to manufacture COVID-19 treatment remdesivir for distribution in 127 countries. According to Gilead, the list consists of nearly all low
- Regeneron Links With Univ. of Colorado to Sequence 450,000 Patients for Drug Researchhttps://modernod.com/news/regeneron-links-with-univ-of-colorado-to-sequence-450000-patients-for-drug-research/2477750/Regeneron Pharmaceuticals launched a new initiative that plans to sequence the DNA of 450,000 patients and compare the results with their health records, to support the company’s drug discovery and personalized medicine efforts, according to a FierceBiotech
- VisionCare Announces CE Mark Approval of the Tsert-SI Delivery System for the CentraSight Treatment Programhttps://modernod.com/news/visioncare-announces-ce-mark-approval-of-the-tsert-si-delivery-system-for-the-centrasight-treatment-program/2477744/VisionCare has received CE Mark for the Tsert-SI delivery system for the CentraSight treatment program, which includes the Implantable Miniature Telescope (by Dr. Isaac Lipshitz). The Tsert-SI delivery system includes a pre-loaded telescope implant injector, which only requires a 6.5mm incision,
- 1-800 Contacts Launches Online Glasses Lens Replacement Brand, Boomerang Lenseshttps://modernod.com/news/covid-19-weekly-review/2477734/1-800 Contacts unveiled Boomerang, an online lens replacement service that provides new lenses for consumers to put in their current glasses without having to visit an eye doctor or optical shop. As the current health crisis began to unfold, and eyecare providers and optical shops began f
- Sight Sciences Introduces the Next-Generation Omni Surgical System for Microinvasive Glaucoma Surgeryhttps://modernod.com/news/sight-sciences-introduces-the-next-generation-omni-surgical-system-for-microinvasive-glaucoma-surgery/2477720/Sight Sciences announced the launch of its next-generation Omni Surgical System for microinvasive glaucoma surgery (MIGS) procedures. The Omni Surgical System combines two distinct angle procedures—ab interno trabeculotomy and transluminal viscoelastic delivery. It is the only MIGS
- NIH Mobilizes National Innovation Initiative For COVID-19 Diagnosticshttps://modernod.com/news/nih-mobilizes-national-innovation-initiative-for-covid-19-diagnostics/2477698/The National Institutes of Health (NIH) announced a new initiative aimed at speeding innovation, development, and commercialization of COVID-19 testing technologies. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx) in
- COVID-19: Evolving Conditions in Asiahttps://modernod.com/news/covid-19-evolving-conditions-in-asia/2477692/
- CooperVision Extends Deadline for Science and Technology Awards Proposalshttps://modernod.com/news/coopervision-extends-deadline-for-science-and-technology-awards-proposals/2477688/CooperVision has extended the submission deadline for its
- Market Scope: COVID-19 Fallout Could Reshape Ophthalmology in Indiahttps://modernod.com/news/market-scope-covid-19-fallout-could-reshape-ophthalmology-in-india/2477647/Market Scope estimates the total ophthalmic market in India in 2020 at $1.3 billion, with an optimistic assumption that the COVID-19 suspension of elective surgeries will last for 2 months or less. The firms forecasts a rapid return to 2019 levels of activity, resulting in an overall 25 percent r
- HHS: Here’s How Remaining $70B in COVID-19 Funding Will Be Distributed to Providershttps://modernod.com/news/hhs-heres-how-remaining-70b-in-covid-19-funding-will-be-distributed-to-providers/2477633/The Trump administration has laid out a plan for how to disperse the remaining $70 billion to providers struggling financially due to the COVID-19 outbreak, according to a FierceHealthcare